الصفحة الرئيسية>>Signaling Pathways>> Cell Cycle/Checkpoint>> CRM1>>Eltanexor Z-isomer

Eltanexor Z-isomer (Synonyms: KPT-8602 (Z-isomer))

رقم الكتالوجGC19213

Eltanexor Z-isomer (KPT-8602 Z-isomer) هو الأيزومر الأقل نشاطًا لـ KPT-8602

Products are for research use only. Not for human use. We do not sell to patients.

Eltanexor Z-isomer التركيب الكيميائي

Cas No.: 1642300-78-4

الحجم السعر المخزون الكميّة
1mg
94٫00
متوفر
5mg
195٫00
متوفر
10mg
262٫00
متوفر
50mg
770٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

KPT-8602 Z-isomer is the less active isomer of KPT-8602. KPT-8602 is a potent CRM1 inhibitor.IC50:In Vitro: KPT 8602 Z-isomer exhibits different inhibitory effects on Z138, MM15, 3T3 cell lines, with IC50s of 100 nM-50 uM, 30 uM, respectively[1]. In Vivo:

References:
[1]. Vercruysse T et al. The second-generation exportin-1 inhibitor KPT-8602 demonstrates potent activity against acute lymphoblastic leukemia. Clin Cancer Res. 2016 Oct 25.
[2]. Hing ZA et al. Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies. Leukemia. 2016 Jun 21.
[3]. Etchin J et al. KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells. Leukemia. 2016 Jun 24.

مراجعات

Review for Eltanexor Z-isomer

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Eltanexor Z-isomer

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.